Interview Released with UBC – An Express Scripts Company: Patient Recruitment & Retention Strategies in Biosimilars Research

Iselin, NJ, July 01, 2016 --(PR.com)-- In the run up to the event, the SMi Group caught up with Shazia Ahmad, Director, Patient & Physician Services, UBC - An Express Scripts Company. Shazia will be leading a pre-conference workshop on November 15th: “Leveraging Successful Patient Recruitment & Retention Strategies in Biosimilars Research.”

In the exclusive interview, Shazia Ahmad said, "I believe one of the major challenges in biosimilars clinical trials is the lack of understanding amongst stakeholders – as well as patients...It’s critical to engage stakeholders and physicians as early on as possible...We encourage establishing a stakeholder community so that we can gauge their interest in the program and by the time you conduct clinical trial PhIII and IV, which involves direct patient recruitment, all stakeholders will have developed a base understanding..."

"Leveraging Successful Patient Recruitment & Retention Strategies in Biosimilars Research" workshop will showcase practical case studies and examples of patient recruitment and retention for biosimilars to drive clinical excellence and thus commercialization.

The full interview, events brochure and a full speaker line up are available at: www.biosimilars-northamerica.com/pcm

Join them at the event this November to hear the latest market developments and regulatory updates to ensure you stay at the forefront of this evolving market. Receive case studies from Vizient and Harvest Moon Pharmaceuticals USA on how to commercialize biosimilars. Hear Boehringer Ingelheim’s thoughts on the best tactic in the US and much more.

Elite speaker panel 2016 :
· Edric Engert, Senior Vice President, Biosimilars, Teva Pharmaceuticals
· Gustavo Grampp, Ph.D., Director R&D Policy - Biosimilars, Amgen Inc.
· Hillel Cohen, Executive Director, Scientifi c Affairs, Sandoz
· Andrew Simpson, Scientifi c Director, Orygen Biotechnologia S/A
· Dr. Jianguo Yang, CEO, Abpro-China; Vice President, Abpro-US
· Daniel Alvarez, Senior Director, Asset Lead, Global Established Pharma, Pfizer Inc.

Attendees are advised to register before 30th June to save $400.

For media enquiries please contact Anna Serazetdinova on +44 20 7827 6180 or aserazetdinova@smi-online.co.uk

For delegate enquiries contact Fateja Begum +44 (0) 20 7827 6184 or email fbegum@smi-online.co.uk

For sponsorship opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk